Crystal Bioscience

Crystal Bioscience operates as a private equity fund of funds with a balanced strategy focused on biotechnology and healthcare. The firm commits to underlying venture and growth equity managers across subsectors including therapeutics, medical devices, and diagnostics. Geographic exposure typically spans North America, Europe, and Asia.

Given the firm's private, relationship-driven structure without a public website, sourcing likely occurs through direct GP relationships cultivated via Korea's dense biotech ecosystem in the Seoul Capital Area. Limited partners and managers gain access through institutional networks such as the Korea Financial Investment Association rather than through open marketing channels.

Available public information describes Crystal Bioscience strictly as a fund-of-funds manager, indicating commitments are made to underlying private equity funds rather than directly into portfolio companies. No direct co-investment or secondary transaction activity has been publicly disclosed.

The names and professional backgrounds of Crystal Bioscience's managing principals have not been publicly disclosed through official filings, a website, or professional networks. The firm operates without a LinkedIn presence as of the latest available information.

Crystal Bioscience is headquartered in Gyeonggi-do, South Korea, within the Seoul Capital Area biocluster. Its underlying fund commitments typically span North America, Europe, and Asia, providing Korean limited partners with diversified global exposure to biotechnology and healthcare venture and growth equity.